🇺🇸 FDA
Pipeline program

TM buprenorphine

INDV-6000-403

Approved small_molecule completed

Quick answer

TM buprenorphine for Opioid-use Disorder is a Approved program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Indivior Pharmaceuticals
Indication
Opioid-use Disorder
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials